Cerebral amyloid angiopathies: A pathologic, biochemical, and genetic view

Journal of Neuropathology and Experimental Neurology

Volumn 62, Issue 9, 2003, Pages 885-898

  Revesz, Tamas ^a   Ghiso, Jorge ^c   Lashley, Tammaryn ^a   Plant, Gordon ^b   Rostagno, Agueda ^c   Frangione, Blas ^c   Holton, Janice L ^a  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

^b NATIONAL HOSPITAL FOR NEUROLOGY AND NEUROSURGERY   (United Kingdom)

^c NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Amyloid proteins; Biochemistry; Cerebral amyloid angiopathy; Genetics; Hereditary cerebral amyloid angiopathies; Pathology

Indexed keywords

AMYLOID; AMYLOID BETA PROTEIN; AMYLOID PRECURSOR PROTEIN; CYSTATIN C; GELSOLIN; GENE PRODUCT; PREALBUMIN; PRESENILIN 1; PRION PROTEIN;

ALZHEIMER DISEASE; ANIMAL MODEL; BR12 GENE; BRAIN HEMORRHAGE; BRAIN ISCHEMIA; CLINICAL FEATURE; DEMENTIA; GENE; GENE MUTATION; GENETIC PREDISPOSITION; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; REVIEW; VASCULAR AMYLOIDOSIS;

EID: 0141566766     PISSN: 00223069     EISSN: None     Source Type: Journal    
DOI: 10.1093/jnen/62.9.885     Document Type: Review

References (80)

1. Frangione B, Revesz T, Vidal R, et al. Familial cerebral amyloid angiopathy related to stroke and dementia. Amyloid 2001;8Suppl 1:36-42
2. Ghiso J, Frangione B. Amyloidosis and Alzheimer's disease. Adv Drug Deliv Rev 2002;54:1539-51
3. Vinters HV. Cerebral amyloid angiopathy. A critical review. Stroke 1987;18:311-24
4. Plant GT, Ghiso J, Holton JL, Frangione B, Revesz T. Familial and sporadic cerebral amyloid angiopathies associated with dementia and the BRI dementias. In: Esiri MM, Lee V-MY, Trojanowski JQ, eds. The neuropathology of dementia. Cambridge: Cambridge University Press, in press
5. Revesz T, Holton JL, Lashley T, et al. Sporadic and familial cerebral amyloid angiopathies. Brain Pathol 2002;12:343-57
6. Vinters HV, Vonsattel JP. Neuropathologic features and grading of Alzheimer-related and sporadic CAA. In: Verbeek MM, de Waal RMW, Vinters HV, eds. Cerebral amyloid angiopathy in Alzheimer's disease and related disorders. Dordrecht: Kluwer Academic Publishers, 2000;137-55
7. Vonsattel JP, Myers RH, Hedley-Whyte ET, Ropper AH, Bird ED, Richardson EP Jr. Cerebral amyloid angiopathy without and with cerebral hemorrhages: A comparative histological study. Ann Neurol 1991;30:637-49
8. Holton JL, Ghiso J, Lashley T, et al. Regional distribution of amyloid-BRI deposition and its association with neurofibrillary degeneration in familial British dementia. Am J Pathol 2001;158:515-26
9. Holton JL, Lashley T, Ghiso J, et al. Familial Danish dementia: A novel form of cerebral amyloidosis associated with deposition of both amyloid-Dan and amyloid-beta. J Neuropathol Exp Neurol 2002;61:254-67
10. Woo D, Sauerbeck LR, Kissela BM, et al. Genetic and environmental risk factors for intracerebral hemorrhage: Preliminary results of a population-based study. Stroke 2002;33:1190-95
11. Greenberg, SM. Clinical aspects and diagnostic criteria of sporadic CAA-related hemorrhage. In: Verbeek MM, de Waal RMW, Vinters HV, eds. Cerebral amyloid angiopathy in Alzheimer's disease and related disorders. Dordrecht: Kluwer Academic Publishers, 2000;3-19
12. Pfeifer LA, White LR, Ross GW, Petrovitch H, Launer LJ. Cerebral amyloid angiopathy and cognitive function: The HAAS autopsy study. Neurology 2002;58:1629-34
13. Winkler DT, Bondolfi L, Herzig MC, et al. Spontaneous hemorrhagic stroke in a mouse model of cerebral amyloid angiopathy. J Neurosci 2001;21:1619-27
14. Cadavid D, Mena H, Koeller K, Frommelt RA. Cerebral beta amyloid angiopathy is a risk factor for cerebral ischemic infarction. A case control study in human brain biopsies. J Neuropathol Exp Neurol 2000;59:768-73
15. Natte R, Maat-Schieman ML, Haan J, Bornebroek M, Roos RA, van Duinen SG. Dementia in hereditary cerebral hemorrhage with amyloidosis-Dutch type is associated with cerebral amyloid angiopathy but is independent of plaques and neurofibrillary tangles. Ann Neurol 2001;50:765-72
16. Grabowski TJ, Cho HS, Vonsattel JP, Rebeck GW, Greenberg SM. Novel amyloid precursor protein mutation in an Iowa family with dementia and severe cerebral amyloid angiopathy. Ann Neurol 2001;49:697-705
17. Kimchi EY, Kajdasz S, Bacskai BJ, Hyman BT. Analysis of cerebral amyloid angiopathy in a transgenic mouse model of Alzheimer disease using in vivo multiphoton microscopy. J Neuropathol Exp Neurol 2001;60:274-79
18. Townsend KP, Obregon D, Quadros A, et al. Proinflammatory and vasoactive effects of Abeta in the cerebrovasculature. Ann N Y Acad Sci 2002;977:65-76
19. Yamada M. Risk factors for cerebral amyloid angiopathy in the elderly. Ann N Y Acad Sci 2002;977:37-44
20. Ellis RJ, Olichney JM, Thal LJ, et al. Cerebral amyloid angiopathy in the brains of patients with Alzheimer's disease: The CERAD experience, Part XV. Neurology 1996;46:1592-96
21. Greenberg SM, Rebeck GW, Vonsattel JP, Gomez-Isla T, Hyman BT. Apolipoprotein E epsilon 4 and cerebral hemorrhage associated with amyloid angiopathy. Ann Neurol 1995;38:254-59
22. Premkumar DR, Cohen DL, Hedera P, Friedland RP, Kalaria RN. Apolipoprotein E-epsilon4 alleles in cerebral amyloid angiopathy and cerebrovascular pathology associated with Alzheimer's disease. Am J Pathol 1996;148:2083-95
23. Alonzo NC, Hyman BT, Rebeck GW, Greenberg SM. Progression of cerebral amyloid angiopathy: Accumulation of amyloid-beta40 in affected vessels. J Neuropathol Exp Neurol 1998;57:353-59
24. Nicoll JA, Burnett C, Love S, et al. High frequency of apolipoprotein E epsilon 2 allele in hemorrhage due to cerebral amyloid angiopathy. Ann Neurol 1997;41:716-21
25. Selkoe DJ. Alzheimer's disease: Genes, proteins, and therapy. Physiol Rev 2001;81:741-66
26. Bogdanovic N, Corder E, Lannfelt L, Winblad B. APOE polymorphism and clinical duration determine regional neuropathology in Swedish APP(670, 671) mutation carriers: Implications for late-onset Alzheimer's disease. J Cell Mol Med 2002;6:199-214
27. Mann DMA, Iwatsubo T, IHARA Y, et al. Predominant deposition of amyloid-beta(42(43)) in plaques in cases of Alzheimer's disease and hereditary cerebral hemorrhage associated with mutations in the amyloid precursor protein gene. Am J Pathol 1996;148:1257-66
28. Levy E, Carman MD, Fernandez-Madrid IJ, et al. Mutation of the Alzheimer's disease amyloid gene in hereditary cerebral hemorrhage, Dutch type. Science 1990;248:1124-26
29. Maat-Schieman ML, van Duinen SG, Bornebroek M, Haan J, Roos RA. Hereditary cerebral hemorrhage with amyloidosis-Dutch type (HCHWA-D): II - A review of histopathological aspects. Brain Pathol 1996;6:115-20
30. Kumar-Singh S, Cras P, Wang R, et al. Dense-core senile plaques in the Flemish variant of Alzheimer's disease are vasocentric. Am J Pathol 2002;161:507-20
31. Farzan M, Schnitzler CE, Vasilieva N, Leung D, Choe H. BACE2, a beta-secretase homolog, cleaves at the beta site and within the amyloid-beta region of the amyloid-beta precursor protein. Proc Natl Acad Sci U S A 2000;97:9712-17
32. Mann DM, Pickering-Brown SM, Takeuchi A, Iwatsubo T. Amyloid angiopathy and variability in amyloid beta deposition is determined by mutation position in presenilin-1-linked Alzheimer's disease. Am J Pathol 2001;158:2165-75
33. Steiner H, Revesz T, Neumann M, et al. A pathogenic presenilin-1 deletion causes abberrant Abeta 42 production in the absence of congophilic amyloid plaques. J Biol Chem 2001;276:7233-39
34. Takao M, Ghetti B, Hayakawa I. et al. A novel mutation (G217D) in the Presenilin 1 gene (PSEN1) in a Japanese family: Presenile dementia and parkinsonism are associated with cotton wool plaques in the cortex and striatum. Acta Neuropathol (Berl) 2002;104:155-70
35. Nochlin D, Bird TD, Nemens EJ, Ball MJ, Sumi SM. Amyloid angiopathy in a Volga German family with Alzheimer's disease and a presenilin-2 mutation (N141I). Ann Neurol 1998;43:131-35
36. Frangione B, Castano EM, Wisniewski T, Ghiso J, Prelli F, Vidal R. Apolipoprotein E and amyloidogenesis. Ciba Found Symp 1996;199:132-41
37. Castano EM, Prelli F, Soto C, et al. The length of amyloid-beta in hereditary cerebral hemorrhage with amyloidosis, Dutch type. Implications for the role of amyloid-beta 1-42 in Alzheimer's disease. J Biol Chem 1996;271:32185-91
38. Van Dorpe J, Smeijers L, Dewachter I, et al. Prominent cerebral amyloid angiopathy in transgenic mice overexpressing the London mutant of human APP in neurons. Am J Pathol 2000;157:1283-98
39. Lansbury PT. Structural neurology: Are seeds at the root of neuronal degeneration? Neuron 1997;19:1151-54
40. Tekirian TL, Saido TC, Markesbery WR, et al. N-terminal heterogeneity of parenchymal and cerebrovascular Abeta deposits. J Neuropathol Exp Neurol 1998;57:76-94
41. Prelli F, Levy E, van Duinen SG, Bots GT, Luyendijk W, Frangione B. Expression of a normal and variant Alzheimer's beta-protein gene in amyloid of hereditary cerebral hemorrhage, Dutch type: DNA and protein diagnostic assays. Biochem Biophys Res Commun 1990;170:301-7
42. Van Nostrand WE, Melchor JP, Cho HS, Greenberg SM, Rebeck GW. Pathogenic effects of D23N Iowa mutant amyloid beta-protein. J Biol Chem 2001;276:32860-66
43. Miravalle L, Tokuda T, Chiarle R, et al. Substitutions at codon 22 of Alzheimer's abeta peptide induce diverse conformational changes and apoptotic effects in human cerebral endothelial cells. J Biol Chem 2000;275:27110-16
44. Verbeek MM, Otte-Holler I, Veerhuis R, Ruiter DJ, de Waal RM. Distribution of A beta-associated proteins in cerebrovascular amyloid of Alzheimer's disease. Acta Neuropathol (Berl) 1998;96:628-36
45. Ghiso J, Jensson O, Frangione B. Amyloid fibrils in hereditary cerebral hemorrhage with amyloidosis of Icelandic type is a variant of gamma-trace basic protein (cystatin C). Proc Natl Acad Sci U S A 1986;83:2974-78
46. Levy E, Lopez-Otin C, Ghiso J, Geltner D, Frangione B. Stroke in Icelandic patients with hereditary amyloid angiopathy is related to a mutation in the cystatin C gene, an inhibitor of cysteine proteases. J Exp Med 1989;169:1771-78
47. Bjarnadottir M, Nilsson C, Lindstrom V, et al. The cerebral hemorrhage-producing cystatin C variant (L68Q) in extracellular fluids. Amyloid 2001;8:1-10
48. Calero M, Pawlik M, Soto C, et al. Distinct properties of wild-type and the amyloidogenic human cystatin C variant of hereditary cerebral hemorrhage with amyloidosis, Icelandic type. J Neurochem 2001;77:628-37
49. Levy E, Sastre M, Kumar A, et al. Codeposition of cystatin C with amyloid-beta protein in the brain of Alzheimer disease patients. J Neuropathol Exp Neurol 2001;60:94-104
50. Crawford FC, Freeman MJ, Schinka JA, et al. A polymorphism in the cystatin C gene is a novel risk factor for late-onset Alzheimer's disease. Neurology 2000;55:763-68
51. Ghiso J, Plant GT, Revesz T, Wisniewski T, Frangione B. Familial cerebral amyloid angiopathy (British type) with nonneuritic amyloid plaque-formation may be due to a novel amyloid protein. J Neurol Sci 1995;129:74-75
52. Benson MD. Leptomeningeal amyloid and variant transthyretins. Am J Pathol 1996;148:351-54
53. Koo EH, Lansbury PT, Kelly JW. Amyloid diseases: Abnormal protein aggregation in neurodegeneration. Proc Natl Acad Sci U S A 1999;96:9989-90
54. Garzuly F, Vidal R, Wisniewski T, Brittig F, Budka H. Familial meningocerebrovascular amyloidosis, Hungarian type, with mutant transthyretin (TTR Asp18Gly). Neurology 1996;47:1562-67
55. Petersen RB, Goren H, Cohen M, et al. Transthyretin amyloidosis: A new mutation associated with dementia. Ann Neurol 1997;41:307-13
56. Vidal R, Garzuly F, Budka H, et al. Meningocerebrovascular amyloidosis associated with a novel transthyretin mis-sense mutation at codon 18 (TTRD 18G). Am J Pathol 1996;148:361-66
57. Kiuru S. Gelsolin-related familial amyloidosis, Finnish type (FAF), and its variants found worldwide. Amyloid: Int J Exp Clin Invest 1998;5:55-66
58. Haltia M, Ghiso J, Prelli F, et al. Amyloid in familial amyloidosis, Finnish type, is antigenically and structurally related to gelsolin. Am J Pathol 1990;136:1223-28
59. Levy E, Haltia M, Fernandez-Madrid I, et al. Mutation in gelsolin gene in Finnish hereditary amyloidosis. J Exp Med 1990;172:1865-67
60. Ghiso J, Haltia M, Prelli F, Novello J, Frangione B. Gelsolin variant (Asn-187) in familial amyloidosis, Finnish type. Biochem J 1990;272:827-30
61. Maury CP, Nurmiaho-Lassila EL, Rossi H. Amyloid fibril formation in gelsolin-derived amyloidosis. Definition of the amyloidogenic region and evidence of accelerated amyloid formation of mutant Asn-187 and Tyr-187 gelsolin peptides. Lab Invest 1994;70:558-64
62. Kiuru S, Salonen O, Haltia M. Gelsolin-related spinal and cerebral amyloid angiopathy. Ann Neurol 1999;45:305-11
63. Prusiner SB. Shattuck lecture-neurodegenerative diseases and prions. N Engl J Med 2001;344:1516-26
64. Ghetti B, Piccardo P, Spillantini MG, et al. Vascular variant of prion protein cerebral amyloidosis with tau-positive neurofibrillary tangles: The phenotype of the stop codon 145 mutation in PRNP. Proc Natl Acad Sci U S A 1996;93:744-48
65. Mead S, James-Galton M, Revesz T, et al. Familial British dementia with amyloid angiopathy: Early clinical, neuropsychological and imaging findings. Brain 2000;123(Pt 5):975-91
66. Plant GT, Revesz T, Barnard RO, Harding AE, Gautier-Smith PC. Familial cerebral amyloid angiopathy with nonneuritic amyloid plaque formation. Brain 1990;113:721-47
67. Vidal R, Frangione B, Rostagno A, et al. A stop-codon mutation in the BRI gene associated with familial British dementia. Nature 1999;399:776-81
68. Vidal R, Revesz T, Rostagno A, et al. A decamer duplication in the 3′ region of the BRI gene originates an amyloid peptide that is associated with dementia in a Danish kindred. Proc Natl Acad Sci U S A 2000;97:4920-25
69. Kim SH, Wang R, Gordon DJ, et al. Furin mediates enhanced production of fibrillogenic ABri peptides in familial British dementia. Nat Neurosci 1999;2:984-88
70. Ghiso J, Holton J, Miravalle L, et al. Systemic amyloid deposits in familial British dementia. J Biol Chem 2001;276:43909-14
71. Rostagno A, Revesz T, Lashley T, et al. Complement activation in chromosome 13 dementias. Similarities with Alzheimer's disease. J Biol Chem 2002;277:49782-90
72. Zlokovic BV. Vascular disorder in Alzheimer's disease: Role in pathogenesis of dementia and therapeutic targets. Adv Drug Deliv Rev 2002;54:1553-59
73. Ghiso J, Calero M, Matsubara E, et al. Alzheimer's soluble amyloid beta is a normal component of human urine. FEBS Lett 1997;408:105-8
74. Ida N, Hartmann T, Pantel J, et al. Analysis of heterogeneous A4 peptides in human cerebrospinal fluid and blood by a newly developed sensitive Western blot assay. J Biol Chem 1996;271:22908-14
75. Yamaguchi H, Yamazaki T, Lemere CA, Frosch MP, Selkoe DJ. Beta amyloid is focally deposited within the outer basement membrane in the amyloid angiopathy of Alzheimer's disease. An immunoelectron microscopic study. Am J Pathol 1992;141:249-59
76. Fukuchi K, Ho L, Younkin SG, et al. High levels of circulating beta-amyloid peptide do not cause cerebral beta-amyloidosis in transgenic mice. Am J Pathol 1996;149:219-27
77. Frackowiak J, Zoltowska A, Wisniewski HM. Non-fibrillar beta-amyloid protein is associated with smooth muscle cells of vessel walls in Alzheimer disease. J Neuropathol Exp Neurol 1994;53:637-45
78. Kalaria RN. Premkumar DR, Pax AB, Cohen DL, Lieberburg I. Production and increased detection of amyloid beta protein and amyloidogenic fragments in brain microvessels, meningeal vessels and choroid plexus in Alzheimer's disease. Brain Res Mol Brain Res 1996;35:58-68
79. Burgermeister P, Calhoun ME, Winkler DT, Jucker M. Mechanisms of cerebrovascular amyloid deposition. Lessons from mouse models. Ann NY Acad Sci 2000;903:307-16
80. Weller RO, Massey A, Newman TA, Hutchings M, Kuo YM, Roher AE. Cerebral amyloid angiopathy-Amyloid beta accumulates in putative interstitial fluid drainage pathways in Alzheimer's disease. Am J Pathol 1998;153:725-33